Akèy › Kansè larinks
Etid klinik pou Kansè larinks ap rekrite nan Etazini
26 etid pou Kansè larinks ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Milwaukee, WI8 etid
- Atlanta, GA8 etid
- Chicago, IL8 etid
- Kansas City, MO7 etid
- St. Louis, MO7 etid
- Edison, NJ6 etid
- Pittsburgh, PA6 etid
- Durham, NC6 etid
- Portland, OR6 etid
- Baltimore, MD6 etid
- Cincinnati, OH6 etid
- Richmond, VA6 etid
- New York City, NY5 etid
- Queens, NY5 etid
- Kansas City, KS5 etid
- Naperville, IL5 etid
- Omaha, NE5 etid
- Philadelphia, PA5 etid
- Oklahoma City, OK5 etid
- Ann Arbor, MI5 etid
- Champaign, IL5 etid
- Charleston, IL5 etid
- Danville, IL5 etid
- Overland Park, KS5 etid
- Irvine, CA5 etid
- Cedar Rapids, IA5 etid
- Duluth, MN5 etid
- Fargo, ND5 etid
- Lansing, MI5 etid
- Stevens Point, WI5 etid
- Joliet, IL5 etid
- Peoria, IL5 etid
- Bloomington, IL5 etid
- Wausau, WI5 etid
- Cape Girardeau, MO5 etid
- O'Fallon, MO4 etid
- Erie, PA4 etid
- Des Moines, IA4 etid
- Los Angeles, CA4 etid
- Little Rock, AR4 etid
Pa eta
- Arizona5 etid
- Arkansas5 etid
- Colorado7 etid
- Connecticut3 etid
- Delaware3 etid
- Florid8 etid
- Georgia8 etid
- Idaho4 etid
- Illinois9 etid
- Indiana4 etid
- Iowa8 etid
- Kalifòni9 etid
- Kansas7 etid
- Kentucky3 etid
- Lwizyàn4 etid
- Maryland7 etid
- Massachusetts7 etid
- Michigan6 etid
- Minnesota7 etid
- Mississippi3 etid
- Missouri9 etid
- Montana5 etid
- Nebraska5 etid
- New Hampshire3 etid
- New Jersey7 etid
- New Mexico3 etid
- New York10 etid
- North Carolina8 etid
- North Dakota5 etid
- Ohio11 etid
- Oklahoma6 etid
- Oregon6 etid
- Pennsylvania9 etid
- South Carolina5 etid
- South Dakota3 etid
- Tennessee3 etid
- Texas5 etid
- Virginia7 etid
- Washington3 etid
- Wisconsin9 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07195734BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06980038Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07441681Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT01365169Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07209189Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Mar 4, 2026 · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 19, 2026 · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 11, 2026 · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2026 · NCT01473784CONFIRM: Magnetic Resonance Guided Radiation Therapy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT04368702Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 11, 2025 · NCT05793151Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Nov 26, 2025 · NCT06080503SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Oct 22, 2025 · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Ap rekriteEtid obsèvasyon
Laj 21 a 90 · Tout sèks · Mizajou Sep 22, 2025 · NCT00900419Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.